Abstract

This study is aimed at exploring the levels of peripheral blood circular RNAs (circRNAs) as biomarker candidates for the diagnosis of new-onset rheumatoid arthritis (RA). The selected twenty-two circRNAs in peripheral blood from new-onset RA patients and healthy controls (HC) were determined by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The levels of hsa_circ_0002715, hsa_circ_0001947, hsa_circ_0000367, and hsa_circ_0035197 were significantly increased in the peripheral blood of new-onset RA patients than in the peripheral blood of HC. And, there were obvious differences in the above four peripheral blood circRNAs between new-onset RA patients and systemic lupus erythematosus (SLE) patients and ankylosing spondylitis (AS) patients. Moreover, there were obvious differences in hsa_circ_0001947 and hsa_circ_0035197 between new-onset RA patients and patients with undiagnosed arthritis (UA). Receiver operating characteristic (ROC) curve analysis suggested that the levels of hsa_circ_0002715 and hsa_circ_0000367 in peripheral blood could distinguish new-onset RA patients from the HC, AS patients, and SLE patients, and the levels of hsa_circ_0001947 and hsa_circ_0035197 in peripheral blood could distinguish new-onset RA patients from the HC, AS patients, SLE patients, and UA patients. The logistic regression model showed that the combination of hsa_circ_0002715 and hsa_circ_0035197 could provide the best diagnostic accuracy with an area under the curve (AUC) of 0.758 (sensitivity: 72.9%, specificity: 71.4%). Moreover, the levels of peripheral blood hsa_circ_0002715 were correlated with swollen joint count (SJC), tender joint count (TJC), disease duration, rheumatoid factor (RF), anticitrullinated protein antibodies (ACPA), and hematologic disorder. And, the levels of peripheral blood hsa_circ_0035197 were correlated with hematologic disorder. This study suggests that the combination of hsa_circ_0002715 and hsa_circ_0035197 in peripheral blood may be a potential biomarker of patients with new-onset RA and may be associated with disease activity.

Highlights

  • Rheumatoid arthritis (RA) is the most common chronic and debilitating systemic autoimmune disease characterized by synovitis, destruction of the joints, and systemic immune and inflammatory manifestations

  • A total of 186 participants were enrolled in this study, including 59 patients with new-onset rheumatoid arthritis (RA), 35 healthy controls (HC), 25 patients with ankylosing spondylitis (AS), 48 patients with systemic lupus erythematosus (SLE), and 19 patients with undiagnosed arthritis (UA)

  • There was no significant difference in the age and gender between the new-onset RA group, the UA group, and the HC group

Read more

Summary

Introduction

Rheumatoid arthritis (RA) is the most common chronic and debilitating systemic autoimmune disease characterized by synovitis, destruction of the joints, and systemic immune and inflammatory manifestations. Current diagnostic methods, including American College of Rheumatology (ACR) classification criteria [2], anticitrullinated protein antibodies (ACPA), and rheumatoid factor (RF), show various disadvantages for the early diagnosis of RA. This may cause early RA patients to be misdiagnosed, and the untimely treatment may lead to a worse clinical outcome [3]. Our previous researches have revealed that peripheral blood hsa_circ_0044235 could regulate the expression of mir-892a and can serve as a potential diagnostic biomarker of RA [18].

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call